https://wikimd.com/index.php?action=history&feed=atom&title=Ruth_PlummerRuth Plummer - Revision history2026-04-24T21:06:40ZRevision history for this page on the wikiMediaWiki 1.44.2https://wikimd.com/index.php?title=Ruth_Plummer&diff=6028145&oldid=prevPrab: CSV import2024-12-07T19:04:06Z<p>CSV import</p>
<p><b>New page</b></p><div>{{Infobox scientist<br />
| name = Ruth Plummer<br />
| image = <!-- Image of Ruth Plummer --><br />
| caption = Professor Ruth Plummer<br />
| birth_date = <!-- Birth date --><br />
| birth_place = <!-- Birth place --><br />
| nationality = British<br />
| fields = Oncology<br />
| workplaces = Newcastle University<br />
| alma_mater = <!-- Alma mater --><br />
| known_for = Development of PARP inhibitors<br />
}}<br />
<br />
'''Ruth Plummer''' is a renowned British oncologist and professor known for her pioneering work in the development of [[PARP inhibitors]], a class of drugs used in the treatment of cancer. She is a leading figure in the field of [[oncology]] and has contributed significantly to clinical trials and cancer research.<br />
<br />
== Early Life and Education ==<br />
Ruth Plummer was born in the United Kingdom. She pursued her medical education at a prestigious university, where she developed an interest in oncology. Her early academic career was marked by a focus on cancer biology and the mechanisms of cancer cell survival.<br />
<br />
== Career ==<br />
Ruth Plummer is a professor of experimental cancer medicine at [[Newcastle University]]. She is also a consultant medical oncologist at the [[Northern Centre for Cancer Care]]. Her work primarily focuses on the development of new cancer therapies, particularly those targeting DNA repair mechanisms in cancer cells.<br />
<br />
=== Research Contributions ===<br />
Plummer's most notable contribution to cancer research is her work on [[PARP inhibitors]]. These inhibitors are a breakthrough in cancer treatment, particularly for [[breast cancer]] and [[ovarian cancer]] patients with [[BRCA1]] or [[BRCA2]] mutations. Her research has been instrumental in the clinical development and approval of these drugs, which have improved survival rates for many cancer patients.<br />
<br />
=== Clinical Trials ===<br />
Ruth Plummer has been involved in numerous clinical trials, testing the efficacy and safety of new cancer treatments. Her work in this area has helped bring several new therapies from the laboratory to the clinic, providing new hope for patients with difficult-to-treat cancers.<br />
<br />
== Awards and Honors ==<br />
Throughout her career, Ruth Plummer has received numerous awards and honors for her contributions to cancer research and treatment. She is recognized as a leader in her field and has been invited to speak at international conferences and symposia.<br />
<br />
== Publications ==<br />
Ruth Plummer has authored and co-authored numerous scientific papers and articles in leading medical journals. Her publications cover a wide range of topics in oncology, including the development of targeted therapies and the role of DNA repair in cancer.<br />
<br />
== Also see ==<br />
* [[Oncology]]<br />
* [[PARP inhibitors]]<br />
* [[BRCA1]]<br />
* [[BRCA2]]<br />
* [[Breast cancer]]<br />
* [[Ovarian cancer]]<br />
<br />
{{Authority control}}<br />
<br />
[[Category:British oncologists]]<br />
[[Category:Women oncologists]]<br />
[[Category:Living people]]<br />
[[Category:Academics of Newcastle University]]</div>Prab